Trial Profile
Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Vernakalant (Primary) ; Flecainide
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 07 Dec 2015 New trial record